Why Lyell Immunopharma, Inc. (LYEL) stock rose 13.7% intraday on Monday, November 9, 2026

Lyell Immunopharma, Inc. (LYEL) traded at $16.89 as of 2:31 PM ET, up 13.66% on Monday, November 9, 2026, on volume of 281,577 shares (1.7× its 3-month average); market value about $400.0M.

LYEL was among the stocks moving 5% or more in an earlier update that day; by the close it was no longer moving that much.

What happened

Nexqual found no SEC filing, earnings release, analyst rating change or insider trade for LYEL on Monday, November 9, 2026 or November 6, 2026. The move may reflect news, sector or market moves, or trading flows that these sources do not capture.

More on LYEL

LYEL stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Other big moves that day: November 9, 2026.

Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 10, 2026 at 16:24 UTC. Not investment advice.

Data source: Nexqual. Last updated: November 10, 2026 at 16:24 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt